Press Releases | Archives
The following is a list of press releases issued in 2018 and 2017 by HepQuant:
2018
- Nov. 15 – Sarah Downing Joins HepQuant as Senior Manager of Quality Affairs
- Nov. 9 – Receives IDE Approval from U.S. FDA to Initiate Clinical Trial of the SHUNT Liver Diagnostic Kit
- Aug. 2 – Sean Bundy Appointed Director of Regulatory and Quality Affairs
- May 9 – HepQuant Chosen to Advance to InnoSTARS Semifinals in China
- Apr. 24 – HepQuant a Finalist for InnoSTARS Denver Competition
- Jan. 25 – HepQuant and CTI Clinical Trial and Consulting Services Announce First Patient Enrolled in Liver Disease Diagnostic Trial
- Jan. 2 – HepQuant to Present Poster as Finalist at RESI San Francisco Innovation Challenge
2017
- Dec. 13 – HepQuant to Present at the 10th Annual Biotech Showcase
- Oct. 12 – HepQuant Presents at Rocky Mountain Life Science Investor and Partnering Conference
- Sep. 30 – HepQuant holding its 2017 Scientific Advisory Board Meeting in Washington D.C. on Saturday, October 21st
- Sep. 28 – HepQuant to Sponsor its First Clinical Study
- Sep. 14 – HepQuant Announces Approval of 4th IDE
- Aug. 31 – HepQuant Completes Third State-Sponsored Grant
- Jul. 1 – Test Inventor and Founder Dr. Everson Accepts Role as CEO
- May 15 – HepQuant Names Clinical Accounts Manager, Lab Operations Manager
- Apr. 15 – Dr. Steve Helmke Appointed Chief Scientific Officer
- Mar. 21 – HepQuant Announces Approval of 3rd IDE
- Mar. 17 – HepQuant Announces Approval of 2nd IDE
- Mar. 9 – HepQuant Announces Approval of 1st IDE